Aeon Global Health Corp. (AGHC) Financial Statements (2024 and earlier)

Company Profile

Business Address 2225 CENTENNIAL DRIVE
GAINESVILLE, 30504
State of Incorp. DE
Fiscal Year End June 30
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
3/31/2018
Q3
12/31/2017
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments521323570723470357
Cash and cash equivalents521323570723470357
Receivables2,6012,4922,7012,5072,6662,468
Inventory, net of allowances, customer advances and progress billings489429408453396398
Inventory489429408453396398
Other undisclosed current assets11010879549339
Total current assets:3,7213,3523,7583,7383,6253,261
Noncurrent Assets
Property, plant and equipment1,0601,1741,2931,4211,5751,780
Deposits noncurrent assets     1010
Deferred tax assets, net  5,8167,3577,357
Other undisclosed noncurrent assets 5,8165,8165,816   
Total noncurrent assets:6,8766,9907,1097,2378,9439,148
TOTAL ASSETS:10,59810,34210,86710,97512,56812,409
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,2244,3244,4275,1754,4074,579
Interest and dividends payable495371237985902816
Taxes payable516516516516  
Accounts payable2,0281,6081,6441,4371,3611,269
Accrued liabilities2,1851,8292,0302,2382,1442,493
Debt    3,0503,1722,545
Deferred rent credit224214204195185
Derivative instruments and hedges, liabilities3862234411,3241,471185
Deferred revenue and credits170
Due to related parties1,698     
Other undisclosed current liabilities249447459608603855
Total current liabilities:7,7815,2085,53110,3529,8378,335
Noncurrent Liabilities
Long-term debt and lease obligation   3,114   
Long-term debt, excluding current maturities   3,114   
Liabilities, other than long-term debt1,6223,57571813511390
Deferred revenue and credits90
Deferred rent credit207183157135113
Due to related parties1,4153,114    
Derivative instruments and hedges, liabilities  279560   
Total noncurrent liabilities:1,6223,5753,83113511390
Total liabilities:9,4038,7839,36310,4879,9508,425
Equity
Equity, attributable to parent, including:1,1951,5591,5054892,6183,984
Preferred stock636363636363
Common stock102626262621
Additional paid in capital47,67446,91546,60045,08944,95844,530
Accumulated deficit(46,552)(45,445)(45,184)(44,689)(4,229)(40,630)
Other undisclosed equity, attributable to parent     (38,200) 
Other undisclosed equity   (0)   
Total equity:1,1951,5591,5054892,6183,984
TOTAL LIABILITIES AND EQUITY:10,59810,34210,86710,97512,56812,409

Income Statement (P&L) ($ in thousands)

6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
3/31/2018
Q3
12/31/2017
Q2
Revenues2,5873,5453,7413,3564,0565,531
Revenue, net5,531
Cost of revenue(1,141)(1,204)(1,457)(827)(958)(889)
Gross profit:1,4462,3412,2852,5293,0974,643
Operating expenses (2,639)(2,303)(2,443)(3,427)(3,244)
Other undisclosed operating income (loss)(1,828)(315)(69)(782) (21)
Operating income (loss):(382)(613)(88)(695)(329)1,378
Nonoperating income (expense)96490(312)118(1,380)131
Investment income, nonoperating116499(135)147(1,286)293
Other nonoperating income (expense)27(9)(129)2(50)(124)
Interest and debt expense (47)(47)(49)64(37)(32)
Other undisclosed income from continuing operations before equity method investments, income taxes      
Income (loss) from continuing operations before equity method investments, income taxes:(333)(170)(449)(513)(1,746)1,477
Other undisclosed income (loss) from continuing operations before income taxes47049(64)3732
Income (loss) from continuing operations before income taxes:(286)(169)(400)(577)(1,709)1,509
Income tax expense (benefit) 15(6)(9)(1,601)(3)(4,493)
Other undisclosed loss from continuing operations      
Loss from continuing operations:(271)(175)(409)(2,177)(1,713)(2,984)
Loss before gain (loss) on sale of properties:(271)(175)(409)(2,177)(1,713)(2,984)
Net loss:(271)(175)(409)(2,177)(1,713)(2,984)
Other undisclosed net income (loss) attributable to parent    (26)26 
Net loss attributable to parent:(271)(175)(409)(2,204)(1,686)(2,984)
Preferred stock dividends and other adjustments(86)(86)(86)(83)(86)(86)
Other undisclosed net loss available to common stockholders, basic    (1)  
Net loss available to common stockholders, diluted:(357)(261)(495)(2,288)(1,772)(3,070)

Comprehensive Income ($ in thousands)

6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
3/31/2018
Q3
12/31/2017
Q2
Net loss:(271)(175)(409)(2,177)(1,713)(2,984)
Comprehensive loss, net of tax, attributable to parent:(271)(175)(409)(2,177)(1,713)(2,984)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: